Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation
Clinical trial NCT07699796 · COMPLETED
Trial details
- NCT number
- NCT07699796
- Sponsor
- Heart, Artery, and Vein Center of Fresno
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-06
- Primary completion
- 2020-11-04
- Enrollment
- 564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.